Synthesized peptide derived from human CtBP1/2 (Phospho Ser158/164)

This antibody detects endogenous levels of CtBP1 only when phosphorylated at Human:Ser158, Mouse:Ser158, Rat:Ser147 and CtBP2 only when phosphorylated at Human:S164, Mouse:Ser164, Rat:Ser164..The name of modified sites may be influenced by many factors, such as species (the modified site was not originally found in human samples) and the change of protein sequence (the previous protein sequence is incomplete, and the protein sequence may be prolonged with the development of protein sequencing technology). When naming, we will use the "numbers" in historical reference to keep the sites consistent with the reports. The antibody binds to the following modification sequence (lowercase letters are modification sites):VQsVE

CTBP1 CTBP

CtBP1/2 (Phospho Ser158/164)

C-terminal-binding protein 1 ;
CtBP1 ;

cofactor:NAD. Required for efficient interaction with E1A. Cofactor binding induces a conformation change. ,function:Involved in controlling the equilibrium between tubular and stacked structures in the Golgi complex (By similarity) . Co-repressor targeting diverse transcription regulators such as GLIS2. Has dehydrogenase activity. ,PTM:ADP-ribosylated; when cells are exposed to brefeldin-A (BFA) . ,PTM:Sumoylation on Lys-428 is promoted by the E3 SUMO-protein ligase CBX4. ,PTM:The level of phosphorylation appears to be regulated during the cell cycle. Phosphorylated upon DNA damage , probably by ATM or ATR. Phosphorylation by HIPK2 on Ser-422 induces proteasomal degradation. ,similarity:Belongs to the D-isomer specific 2-hydroxyacid dehydrogenase family. ,subunit:Interacts with the C-terminus of adenovirus E1A protein , ELK3 and CTIP via their consensus motif P-X-[DNS]-L-[STVA]. Can form homodimers or heterodimers of CTBP1 and CTBP2. Interacts with FOXP2 , HDAC4 , HDAC5 and HDAC9. Interacts with GLIS2 but not GLIS1 or GLIS3 (By similarity) . Interacts with FOXP1 , HIPK2 , PNN and NRIP1. Interacts with ZFHX1B and WIZ. Interacts with Epstein-Barr virus EBNA3 and EBNA6. ,

negative regulation of transcription from RNA polymerase II promoter , regulation of transcription , DNA-dependent ,regulation of transcription from RNA polymerase II promoter , protein amino acid phosphorylation , phosphorus metabolic process , phosphate metabolic process , Golgi organization , negative regulation of cell proliferation , negative regulation of biosynthetic process , negative regulation of macromolecule biosynthetic process , negative regulation of macromolecule metabolic process , negative regulation of gene expression , viral reproduction , phosphorylation ,negative regulation of transcription , viral infectious cycle , viral genome replication , viral reproductive process , negative regulation of cellular biosynthetic process , regulation of cell proliferation , fat cell differentiation , regulation of transcription , negative regulation of transcription , DNA-dependent , negative regulation of nucleobase , nucleoside , nucleotide and nucleic acid metabolic process , white fat cell differentiation , negative regulation of nitrogen compound metabolic process , regulation of RNA metabolic process , negative regulation of RNA metabolic process , oxidation reduction ,

Cytoplasm . Nucleus .

>>Wnt signaling pathway ;
>>Notch signaling pathway ;
>>Pathways in cancer ;
>>Chronic myeloid leukemia